Top

Supportive Care in Cancer

Published in:

01-03-2017 | Original Article

Return to work among breast cancer survivors: A literature review

Authors: Yuanlu Sun, Cheryl L. Shigaki, Jane M. Armer

Published in: Supportive Care in Cancer | Issue 3/2017

Abstract

Purpose

Breast cancer survivors in their employment years are likely to try to go back to work after the primary treatment. Because the literature on return to work among breast cancer survivors is limited, we have undertaken a review of the literature to summarize what is known, including identifying important contributing variables and outcomes. This knowledge may be used to develop hypotheses and potential interventions to support breast cancer survivors who wish to return to work.

Method

We searched the following databases: CINAHL, MEDLINE, SCOUP, and PUBMED, within a 10-year timeframe (2004 to 2014).

Results

The majority of reviewed articles (N = 25) focused on three outcomes: return-to-work period, work ability, and work performance. The most frequently studied independent variables were collapsed into the following groups: health and well-being, symptoms and functioning, work demands and work environment, individual characteristics, and societal and cultural factors. Gaps in the literature include evidence of effective interventions to support return to work among breast cancer survivors and research to better understand the roles of government and business-related policy.

Conclusion

All the studies reported a reduced work engagement and work ability. Employment status and work performance is associated with a combination of individual factors, work environment, culture, and resources.

Implications

Significant gaps are apparent in the literature addressing breast cancer survivorship and return to work. This is a complex problem and it will likely require interdisciplinary research teams to develop effective and feasible interventions for this population.

Available only for authorised users

Global Cancer Facts & Figures 2nd Edition (2011) American Cancer Society. http://cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-027766.pdf. Accessed 4/25/2014

Breast Cancer Facts & figures 2013-2014 (2013) Atlanta: American Cancer Society, Inc. http://cancer.org/acs/groups/content/@research/documents/document/acspc-042725.pdf. Accessed 9/20/2014

Richardson A, Addington-Hall J, Amir Z, Foster C, Stark D, Armes J, Brearley SG, Hodges L, Hook J, Jarrett N, Stamataki Z, Scott I, Walker J, Ziegler L, Sharpe M (2011) Knowledge, ignorance and priorities for research in key areas of cancer survivorship: findings from a scoping review. Br J Cancer 105(SUPPL. 1):S82–S94CrossRefPubMedPubMedCentral

Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2012, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2012/, based on November 2014 SEER data submission, posted to the SEER web site, April 2015.

Petersson LM, Wennman-Larsen A, Nilsson M, Olsson M, Alexanderson K (2011) Work situation and sickness absence in the initial period after breast cancer surgery. Acta Oncol 50(2):282–288CrossRefPubMed

Johnsson A, Fornander T, Rutqvist LE, Vaez M, Alexanderson K, Olsson M (2009) Predictors of return to work ten months after primary breast cancer surgery. Acta Oncol 48(1):93–98CrossRefPubMed

Balak F, Roelen CA, Koopmans PC, Ten Berge EE, Groothoff JW (2008) Return to work after early-stage breast cancer: a cohort study into the effects of treatment and cancer-related symptoms. J Occup Rehabil 18(3):267–272CrossRefPubMed

Molina Villaverde R, Feliu Batlle J, Villalba Yllan A, Jimenez Gordo AM, Redondo Sanchez A, San Jose Valiente B, Gonzalez Baron M (2008) Employment in a cohort of breast cancer patients. Occup Med (Oxford) 58(7):509–511CrossRef

Fantoni SQ, Peugniez C, Duhamel A, Skrzypczak J, Frimat P, Leroyer A (2010) Factors related to return to work by women with breast cancer in northern France. J Occup Rehabil 20(1):49–58CrossRefPubMed

10.

Hansen JA, Feuerstein M, Calvio LC, Olsen CH (2008) Breast cancer survivors at work. J Occup Environ Med 50(7):777–784CrossRefPubMed

11.

Hauglann B, Benth JS, Fossa SD, Dahl AA (2012) A cohort study of permanently reduced work ability in breast cancer patients. J Cancer Surviv 6(3):345–356CrossRefPubMed

12.

Quinlan E, Thomas-MacLean R, Hack T, Kwan W, Miedema B, Tatemichi S, Towers A, Tilley A (2009) The impact of breast cancer among Canadian women: disability and productivity. Work 34(3):285–296PubMed

13.

Carlsen K, Jensen AJ, Rugulies R, Christensen J, Bidstrup PE, Johansen C, Huitfeldt Madsen IE, Dalton SO (2013) Self-reported work ability in long-term breast cancer survivors. A population-based questionnaire study in Denmark. Acta Oncol 52(2):423–429CrossRefPubMed

14.

Lavigne JE, Griggs JJ, Tu XM, Lerner DJ (2008) Hot flashes, fatigue, treatment exposures and work productivity in breast cancer survivors. J Cancer Surviv 2(4):296–302CrossRefPubMed

15.

Lerner D, Amick Iii BC, Rogers WH, Malspeis S, Bungay K, Cynn D (2001) The work limitations questionnaire. Med Care 39(1):72–82CrossRefPubMed

16.

Calvio L, Peugeot M, Bruns GL, Todd BL, Feuerstein M (2010) Measures of cognitive function and work in occupationally active breast cancer survivors. J Occup Environ Med 52(2):219–227CrossRefPubMed

17.

Désiron HAM, Donceel P, de Rijk A, Van Hoof E (2013) A conceptual-practice model for occupational therapy to facilitate return to work in breast cancer patients. J Occup Rehabil 23(4):516–526. doi:10.1007/s10926-013-9427-z CrossRefPubMed

18.

Mehnert A, de Boer A, Feuerstein M (2013) Employment challenges for cancer survivors. Cancer 119(11, Suppl):2151–2159. doi:10.1002/cncr.28067 CrossRefPubMed

19.

Duijts S, Spelten E, Verbeek J (2014) Behavioral determinants of employment status in cancer patients. In: The Handbook of Behavioral Medicine. John Wiley & Sons, Ltd, pp 825-849. doi:10.1002/9781118453940.ch39

20.

Johnsson A, Fornander T, Rutqvist LE, Olsson M (2011) Work status and life changes in the first year after breast cancer diagnosis. Work 38(4):337–346PubMed

21.

Ahn E, Cho J, Shin DW, Park BW, Ahn SH, Noh DY, Nam SJ, Lee ES, Yun YH (2009) Impact of breast cancer diagnosis and treatment on work-related life and factors affecting them. Breast Cancer Res Treat 116(3):609–616CrossRefPubMed

22.

Todd BL, Feuerstein EL, Feuerstein M (2011) When breast cancer survivors report cognitive problems at work. Int J Psychiatry Med 42(3):279–294CrossRefPubMed

23.

Schmalenberger S, Gessert CE, Giebenhain JE, Starr LD (2012) Working after breast cancer treatment: lessons from musicians. Med Probl Performing Artists 27(4):175–180

24.

Schmalenberger S, Gessert CE, Giebenhain JE, Starr LD (2012) Livelihood vs. life: the occupational well-being of women musician survivors of breast cancer. Med Probl Performing Artists 27(1):15–20

25.

Blinder VS, Murphy MM, Vahdat LT, Gold HT, de Melo-Martin I, Hayes MK, Scheff RJ, Chuang E, Moore A, Mazumdar M (2012) Employment after a breast cancer diagnosis: a qualitative study of ethnically diverse urban women. J Community Health 37(4):763–772CrossRefPubMed

26.

Boykoff N, Moieni M, Subramanian SK (2009) Confronting chemo brain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response. J Cancer Surviv 3(4):223–232CrossRefPubMedPubMedCentral

27.

Breckenridge LM, Bruns GL, Todd BL, Feuerstein M (2012) Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors. Psychooncology 21(1):43–53CrossRefPubMed

28.

Cheung YT, Tan EH, Chan A (2012) An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors. Support Care Cancer 20(7):1361–1375CrossRefPubMed

29.

Munir F, Burrows J, Yarker J, Kalawsky K, Bains M (2010) Women’s perceptions of chemotherapy-induced cognitive side affects on work ability: a focus group study. J Clin Nurs 19(9–10):1362–1370CrossRefPubMed

30.

Oberst K, Bradley CJ, Gardiner JC, Schenk M, Given CW (2010) Work task disability in employed breast and prostate cancer patients. J Cancer Surviv 4(4):322–330CrossRefPubMed

31.

Ottati A, Feuerstein M (2013) Brief self-report measure of work-related cognitive limitations in breast cancer survivors. J Cancer Surviv 7(2):262–273CrossRefPubMed

32.

Von Ah D, Habermann B, Carpenter JS, Schneider BL (2013) Impact of perceived cognitive impairment in breast cancer survivors. Eur J Oncol Nurs 17(2):236–241CrossRefPubMed

33.

Mujahid MS, Janz NK, Hawley ST, Griggs JJ, Hamilton AS, Katz SJ (2010) The impact of sociodemographic, treatment, and work support on missed work after breast cancer diagnosis. Breast Cancer ResTreat 119(1):213–220CrossRef

34.

Blinder VS, Patil S, Thind A, Diamant A, Hudis CA, Basch E, Maly RC (2012) Return to work in low-income Latina and non-Latina white breast cancer survivors: a 3-year longitudinal study. Cancer 118(6):1664–1674CrossRefPubMed

35.

Tan FL, Loh SY, Su TT, Veloo VW, Ng LL (2012) Return to work in multi-ethnic breast cancer survivors—a qualitative inquiry. Asian Pac J Cancer Prev: Apjcp 13(11):5791–5797CrossRefPubMed

36.

Hakanen JJ, Lindbohm ML (2008) Work engagement among breast cancer survivors and the referents: the importance of optimism and social resources at work. J Cancer Surviv 2(4):283–295CrossRefPubMed

37.

Tamminga SJ, de Boer AG, Verbeek JH, Frings-Dresen MH (2012) Breast cancer survivors’ views of factors that influence the return-to-work process—a qualitative study. Scand J Work Environ Health 38(2):144–154CrossRefPubMed

38.

Tiedtke C, de Rijk A, Donceel P, Christiaens MR, de Casterle BD (2012) Survived but feeling vulnerable and insecure: a qualitative study of the mental preparation for RTW after breast cancer treatment. BMC Public Health 12:538CrossRefPubMedPubMedCentral

39.

Tiedtke C, Donceel P, Knops L, Desiron H, Dierckx de Casterle B, de Rijk A (2012) Supporting return-to-work in the face of legislation: stakeholders’ experiences with return-to-work after breast cancer in Belgium. J Occup Rehabil 22(2):241–251CrossRefPubMed

40.

Hoving JL, Broekhuizen ML, Frings-Dresen MH (2009) Return to work of breast cancer survivors: a systematic review of intervention studies. BMC Cancer 9:117CrossRefPubMedPubMedCentral

41.

Fismen K, Osland IJ, Fismen E, Borge L, Martinsen EW, Hjort P, Iversen OE, Stanghelle JK (2000) [Rehabilitation of women with breast cancer]. Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke 120(23):2749–2754

42.

Maguire P, Brooke M, Tait A, Thomas C, Sellwood R (1983) The effect of counselling on physical disability and social recovery after mastectomy. Clin Oncol 9(4):319–324PubMed

43.

Sachs SH, Davis JM, Reynolds SA, Spagnola M, Hall P, Bloch A (1980) Postmastectomy rehabilitation in a community hospital. J Fam Pract 11(3):395–401PubMed

44.

Winick L, Robbins GF (1977) Physical and psychologic readjustment after mastectomy: an evaluation of memorial hospitals’ PMRG program. Cancer 39(2):478–486CrossRefPubMed

45.

Hubbard G, Gray NM, Ayansina D, Evans JM, Kyle RG (2013) Case management vocational rehabilitation for women with breast cancer after surgery: a feasibility study incorporating a pilot randomised controlled trial. Trials [Electronic Resource] 14:175

46.

Feuerstein M, Todd BL, Moskowitz MC, Bruns GL, Stoler MR, Nassif T, Yu X (2010) Work in cancer survivors: a model for practice and research. J Cancer Surviv 4(4):415–437CrossRefPubMed

47.

Assis MR, Marx AG, Magna LA, Ferrigno IS (2013) Late morbidity in upper limb function and quality of life in women after breast cancer surgery. Braz J Phys Ther 17(3):236–243CrossRefPubMed

48.

Devoogdt N, Van Kampen M, Christiaens MR, Troosters T, Piot W, Beets N, Nys S, Gosselink R (2011) Short- and long-term recovery of upper limb function after axillary lymph node dissection. European Journal of Cancer Care 20(1):77–86. doi:10.1111/j.1365-2354.2009.01141.x CrossRefPubMed

49.

Hayes SC, Rye S, Battistutta D, DiSipio T, Newman B (2010) Upper-body morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of life. Health Qual Life Outcomes 8. doi:10.1186/1477-7525-8-92

50.

Stubblefield MD, Keole N (2014) Upper body pain and functional disorders in patients with breast cancer. PM and R: J Inj, Funct, Rehabil 6(2):170–183. doi:10.1016/j.pmrj.2013.08.605 CrossRef

51.

Boyages J, Kalfa S, Xu Y, Koelmeyer L, Mackie H, Viveros H, Taksa L, Gollan P (2016) Worse and worse off: the impact of lymphedema on work and career after breast cancer. SpringerPlus 5(1):1–8. doi:10.1186/s40064-016-2300-8 CrossRef

52.

Peugniez C, Fantoni S, Leroyer A, Skrzypczak J, Duprey M, Bonneterre J (2011) Return to work after treatment for breast cancer: single center experience in a cohort of 273 patients. Bull Cancer 98(7):E69–E79PubMed

53.

Chachaj A, Malyszczak K, Pyszel K, Lukas J, Tarkowski R, Pudelko M, Andrzejak R, Szuba A (2010) Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment. Psychooncology 19(3):299–305. doi:10.1002/pon.1573 CrossRefPubMed

54.

Dawes DJ, Meterissian S, Goldberg M, Mayo NE (2008) Impact of lymphoedema on arm function and health-related quality of life in women following breast cancer surgery. J Rehabil Med 40(8):651–658. doi:10.2340/16501977-0232 CrossRefPubMed

55.

Hormes JM, Bryan C, Lytle LA, Gross CR, Ahmed RL, Troxel AB, Schmitz KH (2010) Impact of lymphedema and arm symptoms on quality of life in breast cancer survivors. Lymphology 43(1):1–13PubMed

56.

Pyszel A, Malyszczak K, Pyszel K, Andrzejak R, Szuba A (2006) Disability, psychological distress and quality of life in breast cancer survivors with arm lymphedema. Lymphology 39(4):185–192PubMed

57.

Smoot B, Wong J, Cooper B, Wanek L, Topp K, Byl N, Dodd M (2010) Upper extremity impairments in women with or without lymphedema following breast cancer treatment. J Cancer Surviv 4(2):167–178. doi:10.1007/s11764-010-0118-x CrossRefPubMedPubMedCentral

58.

Taghian NR, Miller CL, Jammallo LS, O’Toole J, Skolny MN (2014) Lymphedema following breast cancer treatment and impact on quality of life: a review. Crit Rev Oncol Hematol 92(3):227–234. doi:10.1016/j.critrevonc.2014.06.004 CrossRefPubMed

59.

Henry NL, Griggs JJ (2009) Complexities of adjuvant endocrine therapy in young premenopausal women. Oncol (Williston Park, NY) 23(6):482–487

60.

Howard-Anderson J, Ganz PA, Bower JE, Stanton AL (2012) Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst 104(5):386–405CrossRefPubMed

61.

Mortimer J, Behrendt CE (2013) Severe menopausal symptoms are widespread among survivors of breast cancer treatment regardless of time since diagnosis. Journal of palliative medicine 16 (9):1130–1134. doi:10.1089/jpm.2012.0585

62.

Gupta P, Sturdee DW, Palin SL, Majumder K, Fear R, Marshall T, Paterson I (2006) Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric 9 (1):49-58. doi:10.1080/13697130500487224

63.

Peppercorn J (2009) Breast cancer in women under 40. Oncol (Williston Park, NY) 23(6):465–474

64.

Arroyo JM, Lopez ML (2011) Psychological Problems Derived from Mastectomy: A Qualitative Study. International Journal of Surgical Oncology Vol. 2011:132461. doi:10.1155/2011/132461

65.

Przezdziecki A, Sherman KA, Baillie A, Taylor A, Foley E, Stalgis-Bilinski K (2013) My changed body: breast cancer, body image, distress and self-compassion. Psychooncology 22 (8):1872-1879. doi:10.1002/pon.3230

66.

Anitei M, Chraif M, Vasile C, Enache RG (2012) The relationship between anxiety, depression and self-esteem in women with breast cancer after surgery. Procedia-Soc Behav Sci 33:124–127. doi:10.1016/j.sbspro.2012.01.096 CrossRef

Title: Return to work among breast cancer survivors: A literature review
Authors: Yuanlu Sun
Cheryl L. Shigaki
Jane M. Armer
Publication date: 01-03-2017
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 3/2017
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-016-3446-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Method

Results

Conclusion

Implications

Please log in to get access to this content

Other articles of this Issue 3/2017

Mental and physical health correlates among family caregivers of patients with newly-diagnosed incurable cancer: a hierarchical linear regression analysis

Effects of a multimodal rehabilitation programme on inflammation and oxidative stress in oesophageal cancer survivors: the ReStOre feasibility study

The role of clinical pharmacists in treatment adherence: fast impact in suppression of chronic myeloid leukemia development and symptoms

Validity and reliability of the Greek version of the xerostomia questionnaire in head and neck cancer patients

Characteristics associated with inter-individual differences in the trajectories of self-reported attentional function in oncology outpatients receiving chemotherapy

The “rocky treatment course”: identifying a high-risk subgroup of head and neck cancer patients for supportive interventions

Keynote webinar | Spotlight on antibody–drug conjugates in cancer